Deerfield Management Company »

Marcus Corporation shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Marcus Corporation (MCS) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Marcus Corporation

Tip: Access up to 7 years of quarterly data

All positions including Marcus Corporation held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marcus Corporation by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $387k 27k 14.58

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Marcus Corporation

Dimensional Fund Advisors
Vanguard Group
Jpmorgan Chase & Co
Bank Of Montreal
Credit Suisse
Pacer Advisors
Orbis Allan Gray
Lazard Asset Management
Kitzinger Lautmann Capital Management
Millennium Management
Two Sigma Investments
Two Sigma Advisers
Bank of New York Mellon
Wells Fargo & Company
Mesirow Financial Investment Management International Equity

View all funds holding Marcus Corporation